Tuapr 2011 figures_web

397 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
397
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Tuapr 2011 figures_web

  1. 1. GLOBAL HIV/AIDS RESPONSE Epidemic update and health sector progress towards Universal Access Progress Report 2011
  2. 2. Adults and children estimated to be living with HIV, by WHO Region, 2010 Europe 2.3 million [2.1 million – 2.5 million] Americas 3.0 million [2.6 million – 3.5 million] South-East Asia Eastern Mediterranean 3.5 million [3.0 million – 3.9 million] 560 000 [410 000 – 790 000] Africa Western Pacific [21.7 million – 24.2 million] [1.1 million – 1.5 million] 22.9 million 1.3 million Total: 34.0 million [31.6 million – 35.2 million]
  3. 3. Estimated number of adults and children newly infected with HIV, by WHO Region, 2010 Europe 190 000 [150 000 – 230 000] Americas 170 000 [120 000 – 240 000] South-East Asia Eastern Mediterranean 210 000 [180 000 – 260 000] 82 000 [54 000 – 130 000] Africa 1.9 million [1.7 million – 2.1 million] Western Pacific 130 000 [88 000 – 190 000] Total: 2.7 million [2.4 million – 2.9 million]
  4. 4. Estimated adult and child deaths from AIDS, by WHO Region, 2010 Europe 99 000 Americas 96 000 [71 000 – 120 000] South-East Asia 230 000 [84 000 – 120 000] [190 000 – 260 000] Eastern Mediterranean 38 000 [27 000 – 53 000] Africa 1.2 million [1.1 million – 1.4 million] Western Pacific 80 000 [64 000 – 99 000] Total: 1.8 million [1.6 million – 1.9 million]
  5. 5. Children (<15 years) estimated to be living with HIV, by WHO Region, 2010 Europe 19 000 Americas 58 000 [44 000 – 74 000] South-East Asia [15 000 – 25 000] Eastern Mediterranean 140 000 [92 000 – 190 000] 42 000 [28 000 – 57 000] Africa 3.1 million [2.8 million – 3.5 million] Western Pacific 39 000 [33 000 – 46 000] Total: 3.4 million [3.0 million – 3.8 million]
  6. 6. Estimated number of children (<15 years) newly infected with, by WHO Region, 2010 Europe 2 400 South-East Asia [1 900 – 2 900] Americas 5 000 [3 200 – 6 900] Eastern Mediterranean 17 000 [11 000 – 25 000] 7 400 [5 200 – 9 800] Africa 350 000 [300 000 – 410 000] Western Pacific 5 000 [3 800 – 6 200] Total: 390 000 [340 000 – 450 000]
  7. 7. Estimated deaths in children (<15 years) from AIDS, by WHO Region, 2010 Europe 1 300 South-East Asia [<1 000 – 1 800] Americas 3 600 [2 100 – 5 100] Eastern Mediterranean 12 000 [6 800 – 18 000] 4 100 [2 800 – 5 500] Africa 230 000 [200 000 – 260 000] Western Pacific 2 700 [2 200 – 3 400] Total: 250 000 [220 000 – 290 000]
  8. 8. Adult HIV prevalence (15–49 years), by WHO Region, 2010 Europe 0.4% [0.4 – 0.5%] Americas 0.5% [0.4 – 0.6%] South-East Asia 0.3% [0.3 – 0.3%] Eastern Mediterranean 0.2% [0.1 – 0.3%] Africa Western Pacific 4.7% [4.5 – 4.9%] Total: 0.8% [0.8 – 0.8%] 0.1% [<0.1 – 1%]
  9. 9. Percentage of women and men who received an HIV test and test results in the 12 months preceding the survey in countries with repeat population surveys, 2003–2010
  10. 10. Number of people receiving antiretroviral therapy in low- and middle-income countries, by region, 2002–2010
  11. 11. Number of people (all age groups) receiving and needing antiretroviral therapy, and percentage coverage in low- and middle-income countries by region, 2009 to 2010
  12. 12. Low- and middle-income countries with estimated antiretroviral therapy coverage levels of 50–69%, 70–79% and 80% or higher as of December 2010
  13. 13. Comparison of number of men and women receiving and estimated to need antiretroviral therapy and percentage coverage, by region, December 2010a
  14. 14. Number of children 0–14 years old and adults on antiretroviral therapy in low- and middle-income countries, by region, December 2010a
  15. 15. Retention rates for antiretroviral therapy at 12, 24 and 60 months for selected countries
  16. 16. Adoption of the preferred medicine in first-line antiretroviral regimens into national antiretroviral therapy guidelines, in reporting low- and middle-income countries, 2010–2011 Not a preferred medicine in first-line antiretroviral regimens according to 2010 WHO recommendations. a
  17. 17. Monitoring Framework of the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive TARGETS AND INDICATORS Source: Countdown to zero: Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive 2011–2015.
  18. 18. Estimated number of children newly infected with HIV in low- and middle-income countries, 2000–2015
  19. 19. Syphilis seropositivity of women attending antenatal care reported by countries in 2010
  20. 20. Percentage of pregnant women who received an HIV test in the past 12 months in low- and middle-income countries by region, 2005 and 2008–2010
  21. 21. Coverage of antiretroviral medicine for preventing mother-to-child transmission: most effective regimens and single-dose nevirapine, low- and middle-income countries, by region, 2010 a
  22. 22. Estimated number of women living with HIV needing and receiving antiretroviral medicine for PMTCT in low- and middle-income countries, 2010
  23. 23. Low- and middle-income countries achieving ≥80% coverage with effective regimens of antiretroviral medicine for preventing mother-to-child transmission, 2010
  24. 24. Countries with the largest contribution to the global gap in reaching 90% of pregnant women living with HIV in need with antiretroviral medicine for preventing mother-to-child transmission, 2010
  25. 25. % of pregnant women living with HIV and their infants who received antiretroviral medicine for preventing mother-to-child transmission, low- and middle-income countries, 2005–2010
  26. 26. Percentage of children living with HIV receiving antiretroviral therapy in low- and middle-income countries, 2005, 2009 and 2010

×